| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 677697 | 73294 | VALSARTAN PHARMAKERN 320 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN PHARMAKERN 320 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 320 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73294/73294_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73294/73294_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-21 | 1 | 1 | 1 | 2016-12-23 | 2016-12-23 | 0 | 2011-05-31 | View Edit Delete | ||||||||||||
| 677709 | 98089007IP1 | PRITOR 80 mg COMPRIMIDOS | PRITOR 80 mg COMPRIMIDOS, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98089007IP1/98089007IP1_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98089007IP1/98089007IP1_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8198 | ELAM PHARMA LABS S.L. | 2011-05-18 | 1 | 1 | 1 | 2011-05-18 | 2011-05-18 | 1 | 2013-09-12 | View Edit Delete | ||||||||||||
| 677713 | 11678001 | HALAVEN 0,44 MG/ML SOLUCION INYECTABLE | HALAVEN 0,44 MG/ML SOLUCION INYECTABLE, 1 vial de 2 ml | 0,44 mg/ml inyectable 2 ml | 45 | 1 | 34 | 1 vial de 2 ml | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11678001/11678001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11678001/11678001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 34732 | EISAI FARMACÉUTICA S.A. | 2011-05-23 | 1 | 1 | 1 | 2011-05-23 | 2011-05-23 | 1 | 2011-07-20 | View Edit Delete | ||||||||||||
| 677718 | 98071003IP3 | XENICAL 120 mg CAPSULAS DURAS | XENICAL 120 mg CAPSULAS DURAS, 84 cápsulas | 120 mg | 5 | 84 | 43 | 84 cápsulas | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/98071003IP3/98071003IP3_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/98071003IP3/98071003IP3_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 25535 | SAIMA PRODUCTOS Y SERVICIOS, S.L.U. | 2011-06-15 | 1 | 1 | 1 | 2011-06-15 | 2011-06-15 | 1 | 2013-09-12 | View Edit Delete | ||||||||||||
| 677720 | 05322001 | YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION | YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION, 1 vial de 3 ml | 0,1 - 300 GBq/ml | 45 | 1 | 34 | 1 vial de 3 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05322001/05322001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05322001/05322001_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12588 | NUCLIBER, S.A. | 2011-06-22 | 1 | 1 | 1 | 2011-06-22 | 2011-06-22 | 0 | 2012-07-02 | View Edit Delete | ||||||||||||
| 677721 | 05322002 | YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION | YTTRIGA PRECURSOR RADIOFARMACEUTICO EN SOLUCION, 1 vial de 10 ml | 0,1 - 300 GBq/ml | 45 | 1 | 34 | 1 vial de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/05322002/05322002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/05322002/05322002_p.pdf | 1 | 0 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 12588 | NUCLIBER, S.A. | 2011-06-22 | 1 | 1 | 1 | 2011-06-22 | 2011-06-22 | 0 | 2012-07-02 | View Edit Delete | ||||||||||||
| 677726 | 11688001 | CINRYZE 500 UNIDADES POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | CINRYZE 500 UNIDADES POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE, 2 viales + 2 viales de disolvente | 500 UI | 45 | 2 | 34 | 2 viales + 2 viales de disolvente | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11688001/11688001_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11688001/11688001_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 32558 | TAKEDA FARMACEUTICA ESPANA S.A. | 2011-08-01 | 1 | 1 | 1 | 2011-08-01 | 2011-08-01 | 1 | 2012-09-10 | View Edit Delete | ||||||||||||
| 677730 | 11687002 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 5 ml | 200 mg/ml inyectable 5 ml | 45 | 10 | 34 | 10 viales de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687002/11687002_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687002/11687002_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2012-07-31 | View Edit Delete | ||||||||||||
| 677732 | 61201 | CAMPRAL 333 mg COMPRIMIDOS RECUBIERTOS | CAMPRAL 333 mg COMPRIMIDOS RECUBIERTOS , 84 comprimidos | 333 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61201/61201_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61201/61201_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4902 | MERCK S.L. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-11 | View Edit Delete | ||||||||||||
| 677734 | 11687005 | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA | HIZENTRA 200 MG/ML SOLUCIÓN INYECTABLE SUBCUTÁNEA, 10 viales de 10 ml | 200 mg/ml inyectable 10 ml | 45 | 10 | 34 | 10 viales de 10 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687005/11687005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687005/11687005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 677742 | 11687012 | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA | HIZENTRA 200 MG/ML SOLUCION INYECTABLE SUBCUTANEA, 20 viales de 20 ml | 4 g inyectable 20 ml | 45 | 20 | 34 | 20 viales de 20 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/11687012/11687012_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/11687012/11687012_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 27753 | CSL BEHRING S.A. | 2011-08-04 | 1 | 1 | 1 | 2011-08-04 | 2011-08-04 | 1 | 2023-11-20 | View Edit Delete | ||||||||||||
| 677743 | 97033005 | AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLE EN PLUMA PRECARGADA | AVONEX 30 microgramos/0,5 ml SOLUCION INYECTABLE EN PLUMA PRECARGADA , 4 plumas precargadas de 0,5 ml + 4 agujas | 30 microgramos | 66 | 4 | 49 | 4 plumas precargadas de 0,5 ml + 4 agujas | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/97033005/97033005_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/97033005/97033005_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 30027 | BIOGEN SPAIN S.L. | 2011-08-05 | 1 | 1 | 1 | 2011-08-05 | 2011-08-05 | 1 | 2012-06-14 | View Edit Delete | ||||||||||||
| 677745 | 07434003IP | AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL | AVAMYS 27,5 mcg/PULVERIZACION PARA SUSPENSION NASAL, 1 frasco de 120 pulverizaciones | 27,5 microgramos/dosis | 34 | 120 | 31 | 1 frasco de 120 pulverizaciones | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/07434003IP/07434003IP_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/07434003IP/07434003IP_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4679 | DIFARMED S.L. | 2011-09-13 | 1 | 1 | 1 | 2011-09-13 | 2011-09-13 | 1 | 2013-09-12 | View Edit Delete | ||||||||||||
| 677748 | 73412 | OLANZAPINA ALTER 5 mg COMPRIMIDOS BUCODISPERSABLE EFG | OLANZAPINA ALTER 5 mg COMPRIMIDOS BUCODISPERSABLE EFG, 28 comprimidos | 5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73412/73412_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73412/73412_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 137 | LABORATORIOS ALTER S.A. | 2011-02-07 | 1 | 1 | 1 | 2011-02-07 | 2011-02-07 | 1 | 2012-01-05 | View Edit Delete | ||||||||||||
| 677989 | 63619 | ZADITEN 0,25 mg/ml COLIRIO EN SOLUCION | ZADITEN 0,25 mg/ml COLIRIO EN SOLUCION , 1 frasco de 5 ml | 0,25 mg/ml | 6 | 5 | 26 | 1 frasco de 5 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/63619/63619_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/63619/63619_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 27777 | LABORATORIOS THEA S.A. | 2001-01-29 | 1 | 1 | 1 | 2001-01-29 | 2001-01-29 | 1 | 2011-10-06 | View Edit Delete | ||||||||||||
| 678005 | 60117 | GENOTONORM KABIPEN 12 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | GENOTONORM KABIPEN 12 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial en dispositivo precargado | 12 mg | 45 | 1 | 34 | 1 vial en dispositivo precargado | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/60117/60117_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/60117/60117_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1993-10-01 | 1 | 1 | 1 | 1993-10-01 | 2011-04-05 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 678006 | 59427 | GENOTONORM KABIPEN 5,3 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE | GENOTONORM KABIPEN 5,3 mg POLVO Y DISOLVENTE PARA SOLUCION INYECTABLE , 1 vial en dispositivo precargado | 5,3 mg | 45 | 1 | 34 | 1 vial en dispositivo precargado | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/59427/59427_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/59427/59427_p.pdf | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 11622 | PFIZER S.L. | 1992-06-01 | 1 | 1 | 1 | 1992-06-01 | 2011-04-05 | 1 | 2012-04-02 | View Edit Delete | ||||||||||||
| 678007 | 3303827505 | YASMIN COMPRIMIDOS RECUBIERTOS | YASMIN COMPRIMIDOS RECUBIERTOS, 21 comprimidos | 3 mg/0,03 mg | 5 | 21 | 10 | 21 comprimidos | 0 | 0 | 0 | 0 | No Disponible | https://cima.aemps.es/cima/pdfs/es/p/3303827505/3303827505_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9965 | EUROMED PHARMA SPAIN S.L. | 2011-04-11 | 1 | 1 | 1 | 2011-04-11 | 2011-04-11 | 1 | 2013-11-12 | View Edit Delete | ||||||||||||
| 678078 | 61185 | ATROVENT MONODOSIS 250 mcg / 2ml SOLUCION PARA INHALACION POR NEBULIZADOR | ATROVENT MONODOSIS 250 mcg / 2ml SOLUCION PARA INHALACION POR NEBULIZADOR , 20 ampollas de 2 ml | 250 microgramos | 37 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61185/61185_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61185/61185_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 470 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 678086 | 61184 | ATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADOR | ATROVENT MONODOSIS 500 mcg/ 2ml SOLUCION PARA INHALACION POR NEBULIZADOR, 20 ampollas de 2 ml | 500 microgramos | 37 | 20 | 40 | 20 ampollas de 2 ml | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61184/61184_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61184/61184_p.pdf | 1 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 470 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-12-01 | 1 | 1 | 1 | 1996-12-01 | 1996-12-01 | 1 | 2011-10-25 | View Edit Delete |
Page 279 of 1036, showing 20 records out of 20704 total, starting on record 5561, ending on 5580